These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38918734)

  • 1. Changes in tubular biomarkers with dietary intervention and metformin in patients with autosomal dominant polycystic kidney disease: a post-hoc analysis of two clinical trials.
    Wang W; You Z; Steele CN; Gitomer B; Chonchol M; Nowak KL
    BMC Nephrol; 2024 Jun; 25(1):206. PubMed ID: 38918734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
    Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
    Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction With Frailty Index and Cognitive Function in Persons With CKD in SPRINT.
    Miller LM; Rifkin D; Lee AK; Kurella Tamura M; Pajewski NM; Weiner DE; Al-Rousan T; Shlipak M; Ix JH
    Am J Kidney Dis; 2021 Oct; 78(4):530-540.e1. PubMed ID: 33647393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary biomarkers at early ADPKD disease stage.
    Petzold K; Poster D; Krauer F; Spanaus K; Andreisek G; Nguyen-Kim TD; Pavik I; Ho TA; Serra AL; Rotar L
    PLoS One; 2015; 10(4):e0123555. PubMed ID: 25875363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIM-1 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease: HALT-PKD Results.
    Griffin BR; You Z; Noureddine L; Gitomer B; Perrenoud L; Wang W; Chonchol M; Jalal D;
    Am J Nephrol; 2020; 51(6):473-479. PubMed ID: 32541154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.
    Bullen AL; Katz R; Lee AK; Anderson CAM; Cheung AK; Garimella PS; Jotwani V; Haley WE; Ishani A; Lash JP; Neyra JA; Punzi H; Rastogi A; Riessen E; Malhotra R; Parikh CR; Rocco MV; Wall BM; Bhatt UY; Shlipak MG; Ix JH; Estrella MM
    Kidney Int; 2019 Aug; 96(2):470-479. PubMed ID: 31262489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
    Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Ix JH; Jogalekar MP; Coca S; Waikar SS; Shlipak MG; Warady BA; Vasan RS; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S; ;
    J Am Soc Nephrol; 2021 Oct; 32(10):2664-2677. PubMed ID: 34544821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease.
    Gevers TJ; Chrispijn M; Wetzels JF; Drenth JP
    BMC Nephrol; 2012 Apr; 13():17. PubMed ID: 22475206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants.
    Bullen AL; Katz R; Jotwani V; Garimella PS; Lee AK; Estrella MM; Shlipak MG; Ix JH
    Am J Kidney Dis; 2021 Sep; 78(3):361-368.e1. PubMed ID: 33857535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study.
    Brosnahan GM; Wang W; Gitomer B; Struemph T; George D; You Z; Nowak KL; Klawitter J; Chonchol MB
    Am J Kidney Dis; 2022 Apr; 79(4):518-526. PubMed ID: 34391872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Urinary Neutrophil Gelatinase-Associated Lipocalin for Predicting the Severity of Renal Functions in Patients With Autosomal-Dominant Polycystic Kidney Disease.
    Vareesangthip K; Vareesangthip K; Limwongse C; Reesukumal K
    Transplant Proc; 2017 Jun; 49(5):950-954. PubMed ID: 28583565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes.
    Chen TK; Coca SG; Thiessen-Philbrook HR; Heerspink HJL; Obeid W; Ix JH; Fried LF; Bonventre JV; El-Khoury JM; Shlipak MG; Parikh CR;
    Am J Nephrol; 2022; 53(11-12):775-785. PubMed ID: 36630924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.
    Moledina DG; Hall IE; Thiessen-Philbrook H; Reese PP; Weng FL; Schröppel B; Doshi MD; Wilson FP; Coca SG; Parikh CR
    Am J Kidney Dis; 2017 Dec; 70(6):807-816. PubMed ID: 28844586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression.
    Messchendorp AL; Meijer E; Boertien WE; Engels GE; Casteleijn NF; Spithoven EM; Losekoot M; Burgerhof JGM; Peters DJM; Gansevoort RT;
    Kidney Int Rep; 2018 Mar; 3(2):291-301. PubMed ID: 29725632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
    Hsu CY; Xie D; Waikar SS; Bonventre JV; Zhang X; Sabbisetti V; Mifflin TE; Coresh J; Diamantidis CJ; He J; Lora CM; Miller ER; Nelson RG; Ojo AO; Rahman M; Schelling JR; Wilson FP; Kimmel PL; Feldman HI; Vasan RS; Liu KD; ;
    Kidney Int; 2017 Jan; 91(1):196-203. PubMed ID: 28029431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
    Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
    Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease.
    Parikh CR; Dahl NK; Chapman AB; Bost JE; Edelstein CL; Comer DM; Zeltner R; Tian X; Grantham JJ; Somlo S
    Kidney Int; 2012 Apr; 81(8):784-90. PubMed ID: 22258321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.